A Case of Post-COVID-19 Subacute Thyroiditis

Mehmood, Maham; Bapna, Monica; Arshad, Misbah

doi:10.7759/cureus.12301

Cited by 28 publications

(27 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SAT is a well-documented clinical sequela of COVID-19 infection [3]. However, several recent case studies describe what we commonly see: COVID-19 infection causing symptoms of hyperthyroidism, rather than hypothyroidism as published by Mehmood et al [4]. This hyperthyroidism also more commonly affects women [5].…”

Section: Discussionmentioning

confidence: 93%

Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism

Whiting¹,

Reyes²,

Ahmad³

et al. 2021

Cureus

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 93%

Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism

Whiting¹,

Reyes²,

Ahmad³

et al. 2021

Cureus

View full text Add to dashboard Cite

show abstract

“…To date, a total of 13 cases of SAT with COVID-19 have been reported (Supplementary Tables 2 and 3) (7)(8)(9)(10)(11)(12)(13)(14)(15)(16). Most reports (7/13, 54%) were from Italy (Supplementary Table 3).…”

Section: Destructive Thyroiditis Subacute Thyroiditis (Sat)mentioning

confidence: 99%

“…SAT is treated with 16-40 mg/day prednisolone followed by tapering within 4-6 weeks ( 7 – 16 ). Atypical SAT is a self-limiting disorder, and therefore can be observed without specific pharmacological treatment ( 29 ).…”

Section: Thyroidal Insults Observed In Covid-19 and Their Managementmentioning

confidence: 99%

Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives

Inaba

Aizawa

2021

Front. Endocrinol.

View full text Add to dashboard Cite

SARS-CoV-2 infection (COVID-19) is currently a tremendous global health problem. COVID-19 causes considerable damage to a wide range of vital organs most prominently the respiratory system. Recently, clinical evidence for thyroidal insults during and after COVID-19 has been accumulated. As of today, almost all non-neoplastic thyroid diseases, i.e., Graves’ disease, Hashimoto’s thyroiditis, subacute, painless and postpartum thyroiditis, have been reported as a complication of COVID-19, and causality by the virus has been strongly implicated in all of them. Similar thyroid problems have been reported in the past with the SARS-CoV outbreak in 2002. In this review, we briefly look back at the reported evidence of alteration in thyroid functionality and thyroid diseases associated with SARS-CoV and then proceed to examine the issue with COVID-19 in detail, which is then followed by an in-depth discussion regarding a pathogenetic link between Coronavirus infection and thyroid disease.

show abstract

“…There is a rising evidence of post-COVID-19 subacute thyroiditis, making its treatment a relevant topic for discussion [5][6][7][8][9][10][11].…”

Section: Introductionmentioning

confidence: 99%

Painful Subacute Thyroiditis Treatment Approach

et al. 2021

View full text Add to dashboard Cite

The aim: The study was aimed to compare the efficiency of intrathyroid steroid injection to oral steroid intake in patients with subacute thyroiditis. Materials and methods: 32 patients with subacute thyroiditis with insufficient result from NSAIDs treatment were randomly divided into two groups. The 1st group received two intrathyroid steroid injections, the 2nd group received oral prednisone. The results of the treatment were evaluated via ultrasound and evaluation of ESR and CRP at 0, 2, 4, 8 and 16 weeks of treatment. Results: Patients of the 1st group showed much faster result at the ultrasound compared to the 2nd group: mean decrease in hypoechogenity area 44,42% vs 16,35% at week 2, p < 0,001; 93,29% vs 75,98% at week 4, p < 0,001; 97,8% vs 95,24% at week 8, p = 0,4; mean decrease in ESR 66,34% vs 51,92% at week 2, p = 0,023; 84,43% vs 74,94% at week 4, p = 0,023; mean decrease in CRP 26,53% vs 20,77% at week 2, p = 0,024, 33,77% vs 29,98%, at week 4, p = 0,026. No side effects were noted during the treatment of patients of the 1st group. Conclusions: Compared to oral steroid intake intrathyroid steroid injection is faster, safer and generally better tolerated by patients.

show abstract

A Case of Post-COVID-19 Subacute Thyroiditis

Cited by 28 publications

References 10 publications

Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism

Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism

Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives

Painful Subacute Thyroiditis Treatment Approach

Contact Info

Product

Resources

About